WallStreetZenWallStreetZen

NASDAQ: PRAX
Praxis Precision Medicines Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PRAX

Based on 13 analysts offering 12 month price targets for Praxis Precision Medicines Inc

Min Forecast
$83.00-73.57%
Avg Forecast
$554.15+76.48%
Max Forecast
$1,245.00+296.5%

Should I buy or sell PRAX stock?

Based on 13 analysts offering ratings for Praxis Precision Medicines Inc.

Strong Buy
Strong Buy
9 analysts 69.23%
Buy
3 analysts 23.08%
Hold
0 analysts 0%
Sell
1 analysts 7.69%
Strong Sell
0 analysts 0%
Although PRAX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates PRAX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their PRAX stock forecasts and price targets.

PRAX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-30
lockedlocked$00.00+00.00%2026-01-28Find Out Why
lockedlocked$00.00+00.00%2026-01-12
lockedlocked$00.00+00.00%2025-12-29Find Out Why
lockedlocked$00.00+00.00%2025-12-15
Jefferies
Top 29%
72
Strong BuyMaintains$450.00+43.31%2025-12-09
Guggenheim
Top 3%
98
Strong BuyMaintains$760.00+142.04%2025-12-09Find out why
TD Cowen
Bottom 9%
9
Strong BuyMaintains$353.00+12.42%2025-12-08Find out why
Truist Securities
Top 2%
99
Strong BuyMaintains$500.00+59.24%2025-12-08Find out why
Needham
Top 1%
100
BuyMaintains$315.00+0.32%2025-12-08

1 of 2

Forecast return on equity

Is PRAX forecast to generate an efficient return?

Company
283.08%
Industry
352.12%
Market
211.34%
PRAX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PRAX forecast to generate an efficient return on assets?

Company
245.32%
Industry
122.26%
PRAX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PRAX earnings per share forecast

What is PRAX's earnings per share in the next 3 years based on estimates from 17 analysts?

Avg 1 year Forecast
-$12.98
Avg 2 year Forecast
-$9.46
Avg 3 year Forecast
$5.52

PRAX revenue forecast

What is PRAX's revenue in the next 3 years based on estimates from 17 analysts?

Avg 1 year Forecast
$6.6M-11.52%
Avg 2 year Forecast
$280.6M+3,659.35%
Avg 3 year Forecast
$707.9M+9,385.46%
PRAX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PRAX revenue growth forecast

How is PRAX forecast to perform vs Biotechnology companies and vs the US market?

Company
350.33%
Industry
116.92%
Market
23.08%
PRAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PRAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PRAX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PRAX$314.00$554.15+76.48%Strong Buy
CYTK$63.19$88.00+39.26%Strong Buy
KRYS$279.24$298.00+6.72%Strong Buy
ABVX$111.15$143.50+29.10%Strong Buy
NUVL$102.89$135.00+31.21%Strong Buy
View Top Biotech Stocks

Praxis Precision Medicines Stock Forecast FAQ

Is Praxis Precision Medicines Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 13 Wall Street analysts covering (NASDAQ: PRAX) stock is to Strong Buy PRAX stock.

Out of 13 analysts, 9 (69.23%) are recommending PRAX as a Strong Buy, 3 (23.08%) are recommending PRAX as a Buy, 0 (0%) are recommending PRAX as a Hold, 1 (7.69%) are recommending PRAX as a Sell, and 0 (0%) are recommending PRAX as a Strong Sell.

If you're new to stock investing, here's how to buy Praxis Precision Medicines stock.

What is PRAX's earnings growth forecast for 2026-2028?

(NASDAQ: PRAX) Praxis Precision Medicines's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.84%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.88%.

Praxis Precision Medicines's earnings in 2026 is -$273,036,000.On average, 17 Wall Street analysts forecast PRAX's earnings for 2026 to be -$324,538,064, with the lowest PRAX earnings forecast at -$505,089,838, and the highest PRAX earnings forecast at -$138,639,756. On average, 14 Wall Street analysts forecast PRAX's earnings for 2027 to be -$236,630,356, with the lowest PRAX earnings forecast at -$360,008,235, and the highest PRAX earnings forecast at -$91,113,628.

In 2028, PRAX is forecast to generate $138,159,618 in earnings, with the lowest earnings forecast at -$251,687,173 and the highest earnings forecast at $772,759,095.

What is PRAX's revenue growth forecast for 2026-2028?

(NASDAQ: PRAX) Praxis Precision Medicines's forecast annual revenue growth rate of 350.33% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 116.92%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.08%.

Praxis Precision Medicines's revenue in 2026 is $7,463,000.On average, 17 Wall Street analysts forecast PRAX's revenue for 2026 to be $165,122,350, with the lowest PRAX revenue forecast at $0, and the highest PRAX revenue forecast at $1,804,942,581. On average, 14 Wall Street analysts forecast PRAX's revenue for 2027 to be $7,016,011,896, with the lowest PRAX revenue forecast at $1,102,816,241, and the highest PRAX revenue forecast at $16,575,753,226.

In 2028, PRAX is forecast to generate $17,702,576,351 in revenue, with the lowest revenue forecast at $4,780,120,737 and the highest revenue forecast at $54,390,596,925.

What is PRAX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: PRAX) forecast ROA is 245.32%, which is higher than the forecast US Biotechnology industry average of 122.26%.

What is PRAX's Price Target?

According to 13 Wall Street analysts that have issued a 1 year PRAX price target, the average PRAX price target is $554.15, with the highest PRAX stock price forecast at $1,245.00 and the lowest PRAX stock price forecast at $83.00.

On average, Wall Street analysts predict that Praxis Precision Medicines's share price could reach $554.15 by Jan 30, 2027. The average Praxis Precision Medicines stock price prediction forecasts a potential upside of 76.48% from the current PRAX share price of $314.00.

What is PRAX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: PRAX) Praxis Precision Medicines's current Earnings Per Share (EPS) is -$12.96. On average, analysts forecast that PRAX's EPS will be -$12.98 for 2026, with the lowest EPS forecast at -$20.20, and the highest EPS forecast at -$5.54. On average, analysts forecast that PRAX's EPS will be -$9.46 for 2027, with the lowest EPS forecast at -$14.40, and the highest EPS forecast at -$3.64. In 2028, PRAX's EPS is forecast to hit $5.52 (min: -$10.06, max: $30.90).

What is PRAX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: PRAX) forecast ROE is 283.08%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.